chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report was received from a pharmacist regarding a patient of unknown age and gender. Information on the concurrent condition, medical history and pertinent drug allergies of the patient were not reported. On 26-NOV-2015 at time- 23:01, the patient was vaccinated with improperly stored RECOMBIVAX HB lot # L016427 (expiry date, dose #, route, dose units and anatomical location were not specified). Concomitant medication was not reported. No adverse events were reported. The high temperature and low temperature at which the product was stored were 2.9 and 2.4 (units unspecified) respectively. There were no Product Quality Complaint (PQC) involved. This is one of several reports received from same reporter. Additional information has been requested.
Employee reports redness and swelling to bilateral toes. Reported symptoms started approximately 3 weeks following second dose of vaccine. Employee has officially reported symptoms. Referred employee for COVID testing.
This spontaneous prospective pregnancy report as received from a patients grandmother, refers to a 21 year old female patient. On an unknown date the patient was vaccinated with the first dose of GARDASIL (dose, route of administration and lot number were not reported). The patient became pregnant (on an unknown date) prior to receiving the first shot of the GARDASIL. The last menstrual period (LMP) and estimated delivery date (EDD) were not reported. The pregnancy outcome was pending. No adverse events were reported. Additional information has been requested.
Chills, weak, headache started on 2/7/21 (day3) unable to work from 2/8/21 through 2/12/21.  Teleheath visit with PCP on 2/9/21.   Symptoms resolved by 2/12/21. Self care with meds (allergy and pain meds) rest, fluids.
Patient received Pfizer COVID vaccine on 1/18/21 (lot # EJ3302), 2/8/21 (lot # EL9263), and 11/23/21 (lot # 30130BA). On 5/29/22, patient was admitted to our inpatient facility (med/surg unit) with acute respiratory failure with hypoxia, COVID-19 infection, CKD 3, and thrombocytopenia. As of today (6/2/22), patient is still admitted in the med/surg unit.
Heart attack within 1.5 months of receiving final dose. 38 year old, physically fit patient has excellent cholesterol, blood pressure, and resting heart rate numbers.
5min p/vax pt had syncopal episode w/tonic/clonic movements w/LOC x 30sec;
This spontaneous report was received from a 27 year old male patient who was a pharmacist and was reporting on himself. The patient's pertinent medical history, drug reactions or allergies and concomitant therapies were not reported. On an unknown date, the patient was vaccinated with his last dose of GARDASIL 9 (dose, route of administration and lot # were not reported). On an unknown date, the patient was experiencing adverse effects from receiving GARDASIL 9. The patient stated that he might consider bringing this case to court. The patient's outcome was unknown. The reporter considered the event to be related to the therapy with GARDASIL 9 (reported as he was experiencing adverse effects experiencing from receiving GARDASIL 9). Additional information is not expected as there was no consent to contact a physician.
Patient received a 4th Hepatitis-B vaccine, had already completed series of 3 as infant
seems to be chronic spontaenous urticaria (based on online research), itchy hives and splotches all over trunk, scalp, neck, arms, legs randomly throughout day. Goes away with antihistamine but returns every day. This was after his booster shot, which he received since he is immunocompromised as he is lacking a spleen. He will see a doctor if it does not resolve itself soon.
The next day I got hurting so bad I couldn't stand up. My feet hurt so bad. Whole body ached. Ran a high fever in my sleep. Woke up, could not be bothered to do anything.  Got congestion in my head and chest, an itchy cough that was so bad I would pass out. And if I moved my head it felt like I would pass out also. In a week I lost my voice and gained horrible pains in my sides as if someone were ripping at my muscles. In another week my left breast turned blue. It felt like it was on fire . And when I moved and my breast it felt like someone was ramming a large knitting needle through it. I got my voice back after weeks of not having it but I still don't sound like myself,  it's hard and I have to strain to talk. As if I'm talking underwater. My throat sticks to itself inside. I have very bad congestion. My side/stomach muscles hurt so bad I can't sit up long without feeling like I'm dying. My breast is still blue and painful. I am heading into my 3rd month with no period, I am extremely hormonal and cranky and now I'm suicidal. Never been that depressed in my life until now. I've been to several Dr's nobody knows what is happening or how to fix it.
Pt presented to office today and relayed the last few weeks symptoms to the MD. Migraines, nausea, diarrhea, myalgia, abdominal cramps, sore throat. Pt has autoimmune diseases and the MD thought that the shot could have exacerbated the symptoms. Pt has been given prescriptions for zofran, and codeine.
Patient indicated no previous COVID-19 vaccination, but after administration (upon recording the shot) it was noted the patient had already received both doses of Pfizer. Patient stated she wanted the additional type of vaccine as reason for indicating no previous history of COVID vaccination.
pt passed out. fell to ground. 911 was called. after testing the pt the EMTs gave pt the all clear
week after 2nd vaccine left arm became in useable she couldn't lift it, getting shooting pains in her left arm. in the middle of May she ended up getting 4 huge welts at the vaccine site and the next month she got cellulitis and blood poisoning also in the back of her leg she got a huge purple spot. on her lower back near her butt she started getting welts. last week she has started getting puffy blisters. all this came about after receiving the 2nd vaccine.
Pt received 1st dose only. Antibodies checked, were negative; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 23-year-old male patient who received HBV (Engerix B) for prophylaxis.   Previously administered products included Engerix B (1st dose received on 12th July 2021 with batch number 74EM4 and expiration date 20th December 2022).   On an unknown date, the patient did not receive the 2nd dose of Engerix B. On an unknown date, unknown after receiving Engerix B, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional Information: GSK Receipt Date: 06-July-2022 Reporter's Comments: The patient received first dose of Engerix-B, but never returned for more doses. The patient was paying out of pocket, so he only got one dose. The patient had antibodies checked for school, and they were negative and at the time of reporting he was in pharmacy requesting second dose, but it has not been administered at the time of reporting. The reporter consented to follow up. Additional Supportive Information: Till the time of reporting, the patient did not receive the 2nd dose of Engerix B, which led to incomplete course of vaccination. VAERS details provided was corresponding to the 1st dose as the 2nd dose was not received yet.
Information has been received from a 46 year old male patient with history of drug hypersensitivity to penicillin and shellfish based medications such as finasteride (MSD) WAES # 0812USA02142) who on 3-DEC-2008 was vaccinated with a dose of ZOSTAVAX (Oka/Merck) (lot # 663198/1419X) on the arm. There was no concomitant medication. On 4-DEC-2008 the patient experienced redness at injection site, swelling at injection site and bump under the skin at injection site. Patient stated that the bump is approximately the size of half a dollar and the redness is about 4 times the size of the bump. Patient sought medical attention going to see the pharmacists. At  the time of the report the patient had not recovered. This is one of several reports from the same patient. Additional information has been requested.
8 cm x 8 cm area of redness and warmth (R) anterior thigh encompassing shot sites where Hep A and PREVNAR were given. No tenderness or induration.
Thyroid storm; Incomplete course of vaccination; A spontaneous report was received from a consumer (patient) concerning 68 years-old, female patient who received Moderna's COVID-19 Vaccine (mRNA-1273) and was hospitalized due to thyroid storm and ill.  The patient's medical history was not reported. No relevant concomitant medications were reported.  On 07-Jan-2021, the patient received their first of two planned doses of mRNA-1273 (lot: 025-J20-2A) intramuscularly for prophylaxis of COVID-19 infection.  On 02-Feb-2021, the patient got ill and went to the hospital for seven days. The patient reported that she had a thyroid storm. The patient stated she did not have side effects from the vaccine first dose.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was unknown.  On 09-Feb-2021, the events of thyroid storm (thyrotoxic crisis) and ill (illness) were resolved.; Reporter's Comments: Based on reporter's causality, the events are assessed as unlikely related to mRNA-1273.
pt recvd vax; 10aug94, quarter size raised red area; 26aug94 flu like sxs, rash on face, on extremities, chest & feet;
I have stared having stomach issues such as pain and bloating, but I don?t think it is due to the vaccine
first dose of Shingrix on July 19th, 2018/ has not received the second dose yet.; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 73-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose on 19th July 2018).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The age at vaccination was not applicable for this report. Till the time of reporting, the patient had not received the 2nd dose of Shingrix, which led to incomplete course of vaccinations. The reporter did not consent to follow up.
Dizziniess, light-headiness, shortness of breath when walking or going upstairs, strange heartbeat periodically mostly at night and body aches
Fever of 101.8; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever of 101.8) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (Fever of 101.8). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, PYREXIA (Fever of 101.8) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.
Eyelid won't close all the way and left side of mouth is numb/not moving. Possibly Bell's Palsy; Eyelid won't close all the way and left side of mouth is numb/not moving. Possibly Bell's Palsy; Eyelid won't close all the way and left side of mouth is numb/not moving. Possibly Bell's Palsy; Eyelid won't close all the way and left side of mouth is numb/not moving. Possibly Bell's Palsy; Eyelid won't close all the way and left side of mouth is numb/not moving. Possibly Bell's Palsy; This is a spontaneous report from a contactable consumer (patient). A 29-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration on 22Mar2021 (Batch/Lot Number: EW0161) at the age of 29 years old, as 2ND DOSE,SINGLE for covid-19 immunisation. Patient received the first dose on 22Mar2021 at the age of 29 years old (lot number: ER8730). The patient medical history was not reported. Concomitant medications included minerals nos, vitamins nos (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) and sunflower lecithin. The patient experienced mild facial numbness on the left side. Eyelid won't close all the way and left side of mouth is numb/not moving. Possibly Bell's Palsy on 03Jun2021 13:30. Ae resulted in: [Doctor or other healthcare professional office/clinic visit]. Outcome of events was Not recovered.
ADMITTED 6/6/2017 WITH MENINGITIS. PATIENT DISCHARGED HOME ON 6/8/2017 IN GOOD HEALTH AFTER  48 HOURS OF  VANCOMYCIN AND ROCEPHIN. AFTER 5 DAYS ALL CULTURES WERE NEGATIVE. PRESUMPTIVE VIRAL MENINGITIS.
Information has been received from a physician concerning a 7 month old female patient who on 30-MAR-2009, 07-AUG-2009 and on 21-AUG-2009 was vaccinated with the first, second and third doses of ROTATEQ (Lot # 663265/1585X: first and second doses) (Lot #663848/0147Y: third dose). No adverse symptoms noted. Additional information has been requested.
10 week old infant patient was given a hepatitis A vaccine as well as a MMR vaccine that were not scheduled to be given until after 12 months of age in addition to the scheduled Hib, hep B, DTap and IPV vaccines.
Parent stated that the child was between the ages of 5 - 11 years old.   After the 12 year old child received the Pediatric Pfizer 5 -11 year old vaccine and the error was identified, the parent stated that she did not want her child of small stature to receive the full dose required for her age.   The child did not experience any adverse events.
No signs or symptoms reported; Administrator report a temperature excursion on ROTATEQ and the doses were administered.; This spontaneous report was received from a administrator referring to a patient of unknown age and gender. The patient's medical history, previous drug reactions or allergies, and concomitant medications were not reported.  On 27-APR-2021, the patient was inadvertently administered with  an improperly stored dose (product storage error) of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) 1 time dose for prophylaxis (strength and route of administration were not reported; lot # 1742458 had been verified to be a valid number; expiration 22-JAN-2022). It was reported the temperature excursion was at 49.0 degrees Fahrenheit (F) on 09-APR-2021 and 48.7 degree F on 23-APR-2021, for a time frame of 1 hour 15 minutes and 0 seconds (cumulative) excursions. It was reported that no had previous temperature excursion. It was reported that the call was not due to data logger. No signs or symptoms reported.  This is one of several reports received from the same reporter.
A couple hours after 2nd dose, my arm was sore. The next morning around 8 am, I started feeling nauseous and freezing cold. No fever. The second dose was November 19, 2021. I am still feeling the same. On December 8, 2021, my boyfriend found me on the floor pale/white. He stated like a piece of paper. He called 911. I was going in and out of consciousness, even in the emergency room. The only thing the ER did was bloodwork and an EKG. They treated me for vertigo.  Since December 9, 2021, I have been feeling like my brain is throbbing.
cellulitus around left eye which spread down left cheek, across chin and started up the right cheek; This is a spontaneous report from a contactable consumer (patient). A 64-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiry date not reported), via an unspecified route of administration, on the left arm, on 16Jan2021 at 12:00, at a single dose for Covid-19 immunization. The patient has no medical history and no known allergies. Concomitant medication included amoxicillin. On 24Jan2021, the patient experienced cellulitis around left eye which spread down left cheek, across chin and started up the right cheek. The adverse event resulted in doctor or other healthcare professional office/clinic visit, hospitalization. The patient was hospitalized for 6 days. The patient has no Covid prior vaccination and was Covid tested post vaccination. The patient had a nasal swab on 28Jan2021 and result was negative. The patient was recovering from the event.  Information on lot/batch number has been requested.
I received both doses of the Covid Vaccine; the first one on 3/18/21 and the second on 4/7/21. On May 26th I came done with Shingles. Thought this may have something to do with the vaccination.
expired Havrix and Engerix-B administered; This case was reported by a pharmacist via call center representative and described the occurrence of expired vaccine used in a 52-year-old male patient who received HAV (Havrix) (batch number J95H7, expiry date 22nd May 2022) for prophylaxis.   Co-suspect products included HBV (Engerix B) (batch number 2573G, expiry date 28th May 2022) for prophylaxis.   On 15th June 2022, the patient received Havrix and Engerix B. On 15th June 2022, unknown after receiving Havrix and Engerix B, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.       Additional Information: GSK receipt date: 15-June-2022 Reporter's comment: The pharmacist reported that expired havrix and engerix-b administered. The reporter consented to follow up. Additional Supportive Information: The patient received expired havrix and engerix-b which led to expired vaccine used. The case been linked with case US2022093622 reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2022093622:Same reporter
Anaphylactic reaction (I could not swallow, I was short of breath, I got 2 bruises on my face, nausea, tachycardia) at the first dose of the Pfizer vaccine, which I was treated immediately in the emergency room with Epinephrine, Benadryl, Decadron y Albuterol. I was discharged the same day. I was treated in observation at hospital.
Pt developed an enlarged axillary lymph node  24 hrs after flu shot injection to the left deltoid. No pain or erythema at the injection site.   Lymph nodes >3 cm and very tender. Range of motion to the left arm limited by the pain experienced in the lymph nodes. Pt sought care on 9/27/21. No fevers. Endorsed fatigue
Progressive severe joint and muscle pain; Progressive severe joint and muscle pain; Headache; Backache; severe neck pain; shoulders immobility; extreme  fatigue; unable to sleep; diminished appetite; twitching; skin crawling; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 67 year-old male patient received bnt162b2 (BNT162B2), administered in arm right, administration date 01Feb2021 10:45 (Lot number: EL9264) at the age of 67 years as dose 2, single and administered in arm right, administration date 13Jan2021 10:00 (Lot number: El1283) as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. Concomitant medication(s) included: BUPROPION; TRAZODONE; FLUOXETINE; LAMOTRIGINE; D3. The following information was reported: ARTHRALGIA (non-serious), MYALGIA (non-serious) all with onset 01Mar2021, outcome "not recovered" and all described as "Progressive severe joint and muscle pain"; HEADACHE (non-serious) with onset 01Mar2021, outcome "not recovered", described as "Headache"; BACK PAIN (non-serious) with onset 01Mar2021, outcome "not recovered", described as "Backache"; NECK PAIN (non-serious) with onset 01Mar2021, outcome "not recovered", described as "severe neck pain"; MUSCULOSKELETAL DISCOMFORT (non-serious) with onset 01Mar2021, outcome "not recovered", described as "shoulders immobility"; FATIGUE (non-serious) with onset 01Mar2021, outcome "not recovered", described as "extreme  fatigue"; INSOMNIA (non-serious) with onset 01Mar2021, outcome "not recovered", described as "unable to sleep"; DECREASED APPETITE (non-serious) with onset 01Mar2021, outcome "not recovered", described as "diminished appetite"; MUSCLE TWITCHING (non-serious) with onset 01Mar2021, outcome "not recovered", described as "twitching"; FORMICATION (non-serious) with onset 01Mar2021, outcome "not recovered", described as "skin crawling". The events "progressive severe joint and muscle pain", "progressive severe joint and muscle pain", "headache", "backache", "severe neck pain", "shoulders immobility", "extreme  fatigue", "diminished appetite", "twitching" and "skin crawling" were evaluated at the emergency room visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of arthralgia, myalgia, headache, back pain, neck pain, musculoskeletal discomfort, fatigue, insomnia, decreased appetite, muscle twitching, formication. additional information :patient not received other vaccine in four weeks, patient take other medications in two weeks (Bupropion, trazadobe, fluoxetine, lamotrigine, D3, lasi), on 12jul2021 patient undergo covid test (Nasal swab) and result of test is negative. No follow-up attempts are possible. No further information is expected.
The pt experienced a large 2 1/2 x 2 1/2 inch whelp that developed at site which was red and hard. Treated with warm compresses. No SOB or fever was noted.
This spontaneous report was received from a consumer refers to herself as a female patient of unknown age. No medical history was reported. On an unknown date, the patient was vaccinated with M-M-R II, (subcutaneous injection, dose and frequency was not provided). No concomitant therapy was reported. On an unknown date, while the patient was pregnant, the titers were drawn showing that she did not have immunity to suspected vaccine. No adverse effects reported. The outcome of the events was unknown. The reporter did not provide the causality between the event and the suspect therapy. Additional information has been requested.
Swelling and pain onset a few hours after the vaccine was administered on 2/22/06. 2/23/06 significant edema down to elbow. Looks like cellulitis. Started Keflex-well F/U.
(+) swelling at site of injection, pruritus, pain. Ice, NSAIDS, prednisone, & - histamines.
Severely swollen eye lid; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 19Jun2021 at 17:00 (at the age of 61-year-old) as a single dose for COVID-19 immunisation. Medical history included bipolar disorder. The patient took unspecified other medication in two weeks. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 20Jun2021 at 21:00, the patient experienced severely swollen eye lid. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the event swollen eye lid was not recovered.   The batch/lot numbers for, BNT162b2, were not provided and will be requested during follow up.
Patient reported on 10-17-14 on phone as having fine itchy rash on whole body. Took BENADRYL for rash and itch. Symptoms were seen 3 days after getting vaccines.